Pharmaceuticals occupiers in Sydney typically cluster in North Sydney, plan ~220 sqft per seat at high-end fit-out ($225–320/sqft), and pay around 1480 AUD/sqft ($89 USD) on Class A.
Pharmaceuticals occupiers in Sydney typically cluster in North Sydney, plan ~220 sqft per seat at high-end fit-out">fit-out ($225–320/sqft), and pay around 1480 AUD/sqft ($89 USD) on Class A.
Pharmaceuticals occupiers in Sydney typically anchor in North Sydney. Tech, telecom, consulting, corporate satellites.
Class A rent in Sydney runs 1480 AUD/sqft ($89 USD) on a 7-year lease with 30 months free. Prime submarkets sit at or modestly above the city index.
Typical pharmaceuticals fit-out targets high-end specification at $225–320/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 220 sqft per seat blended (workstation + circulation + amenity). A 100-headcount pharma office in Sydney typically targets 22,000 sqft of leasable area.
Commercial and medical-affairs teams cluster near academic-medical anchors; large floor plates support cross-functional brand teams. Australia's deepest financial-services, technology, and professional-services talent pool. Average all-in compensation indexes 85.
Headline corporate tax: 30%. Standard 5-10 year lease. Gross or net structure (both common). Australian leases distinguish 'face rent' (headline) from 'effective rent' (face minus incentive). Incentives of 30-40% are now standard — typically structured as rent abatement, fit-out contribution, or both.
| city | Sydney |
|---|---|
| industry | Pharmaceuticals |
| naics | 3254, 5417 |
| preferredSubmarket | North Sydney |
| preferredFitoutSpec | High-end |
| fitoutBand | $225–320/sqft |
| sqftPerSeat | 220 |
| classARentLocal | 1480 AUD/sqft/yr |
| classARentUsd | $89/sqft/yr |
| vacancyPct | 12.6% |
| typicalLeaseYears | 7 |
| typicalRentFreeMonths | 30 |
| talentIndex | 85 |
| corporateTaxPct | 30% |
Reviewed by Kenji Watanabe — APAC contributing editor. Last updated 2026-04-15. See our methodology and editorial standards.